Archive

Year: 2017

All Year: 2017 Articles

Newest first · Page 468

Why This Seizure Drug Matters So Much for Marinus Pharma

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) saw its shares climb on Monday after the company reported positive preliminary results from its mid-stage trial. Specifically the data came from Mirna’s Phase 2 study evaluating ganazolone as…

Chris Lange · 10 years ago

Why Credit Suisse Sees Incyte Rising Over 15%

Credit Suisse sees future earnings growth from Incyte’s pipeline, with epacadostat’s potential as a best-in-class immunotherapy combination agent making the stock an attractive takeout target.

Chris Lange · 10 years ago

Why Credit Suisse Sees 25% Upside at BioMarin

BioMarin Pharmaceutical may have missed out on the Trump rally, but it might not be too late to catch a ride on the wave, at least according to one analyst.

Chris Lange · 10 years ago

Amazon Expands Into the Auto Parts Industry

Amazon.com has been a dominant force in the markets for the past few years. This giant has been competing with the likes of Wal-Mart and Target, but now Amazon has set its sights on…

Chris Lange · 10 years ago

What to Expect From Major Metal Stocks Reporting Tuesday

24/7 Wall St. has put together a preview of major metal companies reporting their earnings this week. Considering the new Trump administration has been positive for industrials, we could expect to see some upside…

Chris Lange · 10 years ago